Dealmaking

Shore Capital explores sale of Mission Veterinary Partners, two execs from Shamrock raising debut fund

Shore Capital Partners is considering a sale of Mission Veterinary Partners and Coral Tree targets $350 million for inaugural fund.

Shore Capital's Mission Veterinary Partners explores sale

The chain of general practice vet hospitals has grown quickly and successfully via an M&A-driven playbook, but that adds complexity in valuing the Detroit-based business.

Supply chain delays, persistent inflation provide challenges, opportunities for private equity

Some PE firms learned that CEOs who showed a good combination of empathy and energy led their teams through the crisis, and the ones that showed too little of either really struggled.

Private Equity Jobs of the Week: Bain Capital, Z Capital and Endicott are hiring

This week’s jobs include a VP at Z Capital and associates at Bain Capital and Endicott.

Click Therapeutics snags $52m Series B

Click Therapeutics Inc, a provider of digital therapeutics as prescription medical treatments, has raised $52 million in Series B financing.

Wellspring clinches third home care deal with Caring Brands, H&F and EQT jointly bid for Zooplus, VSS makes 3x-plus on Coretelligent

Wellspring acquires Caring Brands while H&F and EQT jointly pursue Zooplus.

VSS Capital makes more than 3x its money on Coretelligent

During the PE firm's five-year investment, the IT solutions business grew EBITDA by about 3x to close to $12m, a source says.

Wellspring buys Caring Brands, its third home care deal in less than eight years

Levine Leichtman sells the international home care franchisor, whose offerings span skilled nursing, home health, assistance with daily living activities, end-of-life hospice care and healthcare staffing.

Arctos taps ex-professional athlete Hutchison as partner

Prior to joining Arctos, Hutchinson served as a managing director at Sixth Street.

EyeCare Partners inks $600m add-on, Partners Group bans 'deal' terminology, Blue Wolf carves out CIVCO Radiotherapy from Roper

Partners' EyeCare Partners buys Revelstoke's CVP while Blue Wolf buys Roper's radiotherapy arm.